Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06205368 · ClinicalTrials.gov registry record · NA

Evaluating the Effectiveness of a Mobile HIV Prevention App to Increase HIV and Sexually Transmitted Infections (STI) Testing and PrEP Initiation Among Rural Men Who Have Sex With Men

A NA study of HIV Infections and HIV Pre-exposure Prophylaxis, sponsored by Emory University.

Active
Registry status
NA
Development phase
473
Enrollment target
1
Study location

NCT06205368 is a NA study of HIV Infections and HIV Pre-exposure Prophylaxis that is active but no longer recruiting, run by Emory University. The registered enrollment target is 473 participants, roughly in line with the 445-participant average among 542 other HIV Infections trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06205368, a NA study of HIV Infections and HIV Pre-exposure Prophylaxis, is active but no longer recruiting, sponsored by Emory University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
473 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to test the efficacy of a mobile app, Combine, to increase the uptake of HIV and STI testing and pre-exposure prophylaxis (PrEP) over 24 months and to assess the effects of different implementation strategies on intervention maintenance among GBMSM in rural southern United States. The main aims of the study are: * To assess the relative effects of three treatment conditions on gains in engagement in HIV prevention compared to a modified standard of care control condition * Measure and assess secondary factors affecting app implementation * Refine implementation strategies and coordinate with potential funders Participants will download an HIV prevention smartphone app and be randomly assigned to one of four groups: * Control: App access only * Self-testing: App access + ability to order HIV and STI self-test kits * Motivational interview: App access + motivational interview to develop plans to use app effectively. * Self-testing + motivational interview: App access + ability to order HIV and STI self-test kits + motivational interview to develop plans to use app effectively. Researchers will compare each of the latter three groups to the control condition to see if HIV and STI testing increase in these groups

Conditions Studied

HIV Infections HIV Pre-exposure Prophylaxis STI

Interventions

  • BEHAVIORAL Combine mobile app
  • BEHAVIORAL Motivational interview
  • BEHAVIORAL HIV/STI testing

Study Locations (1)

Georgia

  • Emory University - Atlanta

Trial Details

FieldValue
Enrollment Target 473 participants
Start Date 2024-03-27
Est. Completion 2027-08
Phase NA

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06205368

The ClinicalTrials.gov registry entry for NCT06205368 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 473 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 445-participant average among 542 other HIV Infections trials with a reported enrollment target. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 3 interventions - of which Combine mobile app is the first listed.

NCT06205368 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT06205368 about?

NCT06205368 is a clinical study titled "Evaluating the Effectiveness of a Mobile HIV Prevention App to Increase HIV and Sexually Transmitted Infections (STI) Testing and PrEP Initiation Among Rural Men Who Have Sex With Men". The goal of this clinical trial is to test the efficacy of a mobile app, Combine, to increase the uptake of HIV and STI testing and pre-exposure prophylaxis (PrEP) over 24 months and to assess the effects of different implementation strategies on intervention maintenance among GBMSM in rural souther...

What is the current status of trial NCT06205368?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 473 participants. The study started on 2024-03-27. Estimated completion is 2027-08.

What conditions does trial NCT06205368 study?

This clinical trial studies the following conditions: HIV Infections, HIV Pre-exposure Prophylaxis, STI.

What interventions are being tested in trial NCT06205368?

The interventions under investigation include: Combine mobile app (BEHAVIORAL), Motivational interview (BEHAVIORAL), HIV/STI testing (BEHAVIORAL).

Who is sponsoring clinical trial NCT06205368?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06205368 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

HIV Pre-exposure Prophylaxis

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.